SCHEMBL8206710

SCHEMBL8206710

CCCCN(C)Cc1ccc(C(=O)NN(c2nc(N)ncc2Cl)C2CCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 7/20 0.39
SIGMAR1 Q99720 7/20 0.39
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
F10 P00742 1/20 0.35
USP7 Q93009 2/20 0.35
USP10 Q14694 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
HSD11B1 P28845 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
LCK P06239 1/20 0.34
JAK3 P52333 1/20 0.34
ACVR1 Q04771 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8206008 0.97 TMEM97 (0.38) TMEM97SIGMAR1DRD2DRD3F10
SCHEMBL8209422 0.95 DRD2 (0.37) TMEM97SIGMAR1DRD2DRD3F10
SCHEMBL8206010 0.91 F10 (0.42) TMEM97SIGMAR1DRD2DRD3F10
SCHEMBL8203780 0.90 SIGMAR1 (0.44) TMEM97SIGMAR1DRD2DRD3USP7
SCHEMBL8205988 0.88 ACVR1 (0.43) F10HDAC1LCKJAK3ACVR1
SCHEMBL8205845 0.88 HDAC1 (0.41) TMEM97SIGMAR1DRD2DRD3USP7
SCHEMBL3166033 0.87 CTSK (0.41) TMEM97SIGMAR1USP7USP10HSP90AA1
SCHEMBL8209425 0.87 S1PR1 (0.35) DRD2DRD3F10HDAC1HDAC6
SCHEMBL8193280 0.87 HDAC6 (0.42) F10HDAC1HDAC6HDAC3LCK
SCHEMBL8193482 0.87 ITK (0.41) TRPV1LCKJAK3ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008052934-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-05-08 WO disclosed